Carbonic anhydrase inhibition and chemoreflex control of breathing: A litmus test for methazolamide as a viable alternative to acetazolamide

Volume: 105, Issue: 2, Pages: 230 - 231
Published: Jan 15, 2020
Abstract
Carbonic anhydrase inhibitors are used in clinical, experimental and environmental settings to regulate acid–base balance in the blood and tissues. Acetazolamide is a carbonic anhydrase inhibitor routinely prescribed in the treatment of pulmonary disorders, glaucoma and sleep-disordered breathing. It is also commonly used prophylactically and therapeutically in acute mountain sickness. In the context of high altitude, acetazolamide is used to...
Paper Details
Title
Carbonic anhydrase inhibition and chemoreflex control of breathing: A litmus test for methazolamide as a viable alternative to acetazolamide
Published Date
Jan 15, 2020
Volume
105
Issue
2
Pages
230 - 231
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.